-
Company Profile
![]()
Sitecore Corp AS – Company Profile
Sitecore Corp AS (Sitecore), a subsidiary of Sitecore Holding II AS, is a provider of management software and web context marketing platform solutions. The company offers content cloud, engagement cloud and commerce cloud platform products. Its major offerings include Content Hub One, XM Cloud, Digital Experience Platform (DXP), Sitecore CDP and OrderCloud. Sitecore’s solution portfolio comprises personalization and testing, marketing automation, order management, customer data management, content management, search and merchandising, digital asset management, content operations, storefront and marketplaces. It...
Add to Basket -
Product Insights
![]()
Keene CDP liquids storage terminal, United States
Keene CDP liquids storage terminal is located in North Dakota, United States. It started operations in 1955. Empower your strategies with our Keene CDP liquids storage terminal, United States report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability...
-
Company Profile
![]()
SIA SpA – Company Profile
SIA SpA (SIA), a subsidiary of CDP Equity, is a provider of technology solutions with focus on cards, e-payments, network services and capital markets. It designs, creates and manages technology infrastructures and services for financial institutions, corporate and public administration bodies. It offers payment systems, payment cards, capital market solutions, interbank corporate banking solutions, network services and database management. It offers multi-channel collection and payment services for utility bills and postal payments and develops back-office products for the banking sector,...
Add to Basket -
Company Profile
![]()
Bango Plc – Company Profile
Bango plc (Bango) is a developer, marketer and seller of technology. It enables mobile phone users to make payments for digital content and media on smartphones and tablets. The company offers services including the provision of a mobile payment platform allowing end users to purchase content and the provision of services to digital merchants and other organizations. Bango’s product portfolio includes Bango payment platform, Audiens CDP, Bango boost, Bango dashboard and Bango platform operations. Bango's customers include s Amazon, Google,...
Add to Basket -
Company Profile
![]()
Breakthru Beverage Group LLC – Company Profile
Breakthru Beverage Group LLC (Breakthru Beverage) engages in the wholesale distribution of alcohol beverages. The company’s product portfolio includes spirits, wine, beer, non-alcoholic, craft, emerging, Japanese beverages. Its products are under various brand names such as 14 hands derby red, 44 degrees north idaho potato, 7 up, a brunel cdp rouge, abita amber, and abita soda vanilla cream. Breakthru Beverage also provides ad laws secale straight rye, afro head rum and 15yr old xo, agave loco tequila. The company has...
Add to Basket -
Product Insights
![]()
Net Present Value Model: Dapirolizumab pegol
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Dapirolizumab pegol Drug Details Dapirolizumab pegol...
-
Product Insights
![]()
Net Present Value Model: Evenity
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Evenity Drug Details Romosozumab (Evenity) is...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – dapirolizumab pegol
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry dapirolizumab pegol Drug Details Dapirolizumab pegol (CDP-7657) is under development for the treatment of...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – olokizumab
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry olokizumab Drug Details Olokizumab (Artlegia) is a humanized monoclonal antibody. It is formulated as...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – romosozumab
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry romosozumab Drug Details Romosozumab (Evenity) is a humanized monoclonal antibody. It is formulated as...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.